In this webinar, Dr. Kleinman will share best practices from her extensive experience to help educate oncology researchers in order to improve their tumor engraftment results:
- ✔ Protocols for use of basement membrane in tumor cell injection:
- » Injection site considerations
- » Tissue/cell type considerations
- ✔ Common issues with tumor uptake
- ✔ Helpful troubleshooting tips for unsuccessful in vivo tumor research
Dr. Hynda K. Kleinman, Ph.D.
Science Advisor, Trevigen Inc.
Former Chief, Cell Biology Section, CDBRB, NIDCR, NIH
Wednesday, November 14th at 11:00 AM EDT (Eastern)
5:00 PM (Europe CET)
About the Speaker:
Hynda is a co-inventor of basement membrane matrix and the Invasion Assay. During her 30 year career at the NIH, Dr. Kleinman’s research generated 9 patents. She has published over 400 papers in the areas of angiogenesis, invasion, 3D culture, tumor growth and metastasis, wound healing, and basement membrane matrices. She has participated in many Advisory Committees and won numerous awards for her work.
Click the following links to review the speaker’s biography and publications.
Trevigen is focused on providing oncology investigators with the quality products they can rely on for the best results. We are dedicated to providing the highest quality Cultrex Basement Membrane Extract for tumor grafts, purified proteins qualified for stem cell work and cancer cell assay kits.